SignatureFD’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

SignatureFD’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-175	Closed	-$5K	–	3297
2021 Q2	$5K	Buy	175 +122	+230%	+$2.4K	﹤0.01%	2326
2021 Q1	$1K	Hold	53	–	–	﹤0.01%	2739
2020 Q4	$1K	Hold	53	–	–	﹤0.01%	2525
2020 Q3	$1K	Sell	53 -44	-45%	-$678	﹤0.01%	2553
2020 Q2	$2K	Buy	+97	New	+$1.46K	﹤0.01%	2234

SignatureFD's TBIO Position: Q3 2021 in Review

SignatureFD sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 175 shares — an estimated $5K sold.

SignatureFD first reported a position in TBIO in Q2 2020 and held it in 5 quarters. The position peaked at $5K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

SignatureFD reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
SignatureFD sold 175 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $5K.
SignatureFD first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
SignatureFD's Translate Bio, Inc. Common Stock position peaked at $5K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on SignatureFD's 13F filing for Q3 2021, filed 28 Oct 2021.